UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 115

Sortiert nach

Human Hypertension Is Characterized by a Lack of Activation of the Antihypertensive Cardiac Hormones ANP and BNP

Journal of the American College of Cardiology, 2012-10, Vol.60 (16), p.1558-1565

2012

Volltextzugriff (PDF)

Neutral endopeptidase inhibition and the natriuretic peptide system: an evolving strategy in cardiovascular therapeutics

European heart journal, 2013-03, Vol.34 (12), p.886-893

2013

Volltextzugriff (PDF)

Vasopressin-2-receptor antagonism augments water excretion without changes in renal hemodynamics or sodium and potassium excretion in human heart failure

American journal of physiology. Renal physiology, 2006-02, Vol.290 (2), p.F273-F278

2006

Volltextzugriff (PDF)

Spatial Relationship of Focal Impulses, Rotors and Low Voltage Zones in Patients With Persistent Atrial Fibrillation

Journal of cardiovascular electrophysiology, 2016-05, Vol.27 (5), p.507-514

2016

Volltextzugriff (PDF)

A Genetic Variant of the Atrial Natriuretic Peptide Gene Is Associated With Cardiometabolic Protection in the General Community

Journal of the American College of Cardiology, 2011-08, Vol.58 (6), p.629-636

2011

Volltextzugriff (PDF)

Natriuretic Peptides in the Diagnosis and Management of Chronic Heart Failure

Heart failure clinics, 2009-10, Vol.5 (4), p.501-514

2009

Volltextzugriff (PDF)

Impaired Natriuretic and Renal Endocrine Response to Acute Volume Expansion in Pre-Clinical Systolic and Diastolic Dysfunction

Journal of the American College of Cardiology, 2011-11, Vol.58 (20), p.2095-2103

2011

Volltextzugriff (PDF)

Transcatheter Aortic Valve Implantation: Addressing the Subsequent Risk of Permanent Pacemaker Implantation

Journal of cardiovascular development and disease, 2023-05, Vol.10 (6), p.230

2023

Volltextzugriff (PDF)

Brain Natriuretic Peptide Is Produced in Cardiac Fibroblasts and Induces Matrix Metalloproteinases

Circulation research, 2002-12, Vol.91 (12), p.1127-1134

2002

Volltextzugriff (PDF)

Pre-procedural predictors for multiple clips in percutaneous edge-to-edge mitral valve repair

The Egyptian heart journal, 2021-09, Vol.73 (1), p.79-79, Article 79

2021

Volltextzugriff (PDF)

Des-serine-proline brain natriuretic peptide 3-32 in cardiorenal regulation

American journal of physiology. Regulatory, integrative and comparative physiology, 2007-02, Vol.292 (2), p.R897-R901

2007

Volltextzugriff (PDF)

Sustained Blood Pressure–Lowering Actions of Subcutaneous B-Type Natriuretic Peptide (Nesiritide) in a Patient With Uncontrolled Hypertension

Mayo Clinic proceedings, 2012-04, Vol.87 (4), p.413-415

2012

Volltextzugriff (PDF)

The novel use of retrograde CTO PCI techniques as a rescue strategy for an acute right coronary artery occlusion due to iatrogenic dissection

Journal of cardiology cases, 2018-03, Vol.17 (3), p.89-91

2018

Volltextzugriff (PDF)

Cardiac Resynchronization Therapy Improves Renal Function in Human Heart Failure With Reduced Glomerular Filtration Rate

Journal of cardiac failure, 2008-09, Vol.14 (7), p.539-546

2008

Volltextzugriff (PDF)

Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure

Circulation (New York, N.Y.), 2004-04, Vol.109 (13), p.1680-1685

2004

Volltextzugriff (PDF)

Cardiorenal and humoral properties of a novel direct soluble guanylate cyclase stimulator BAY 41-2272 in experimental congestive heart failure

Circulation (New York, N.Y.), 2003-02, Vol.107 (5), p.686-689

2003

Volltextzugriff (PDF)

Matrix metalloproteinases: pathways of induction by bioactive molecules

Heart failure reviews, 2004-01, Vol.9 (1), p.53-61

2004

Volltextzugriff (PDF)

Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community : Determinants and detection of left ventricular dysfunction

Journal of the American College of Cardiology, 2006-01, Vol.47 (2), p.345-353

2006

Volltextzugriff (PDF)

The Effect of the Brain-Type Natriuretic Peptide Single-Nucleotide Polymorphism rs198389 on Test Characteristics of Common Assays

Mayo Clinic proceedings, 2011-03, Vol.86 (3), p.210-218

2011

Volltextzugriff (PDF)

Cardiac natriuretic peptides: contributors to cardiac cachexia or possible anti-obesity agents or both?

Diabetes (New York, N.Y.), 2012-10, Vol.61 (10), p.2403-2404

Costello-Boerrigter, Lisa C

2012

Volltextzugriff (PDF)

Renal and anti-aldosterone actions of vasopressin-2 receptor antagonism and B-type natriuretic peptide in experimental heart failure

Circulation. Heart failure, 2010-05, Vol.3 (3), p.412-419

2010

Volltextzugriff (PDF)

Secretion of Prohormone of B-Type Natriuretic Peptide, proBNP1-108 , Is Increased in Heart Failure

JACC. Heart failure, 2013-06, Vol.1 (3), p.207-212

2013

Volltextzugriff (PDF)

Oral human brain natriuretic peptide activates cyclic guanosine 3',5'-monophosphate and decreases mean arterial pressure

Circulation (New York, N.Y.), 2005-08, Vol.112 (6), p.836-840

2005

Volltextzugriff (PDF)

Controlling the Flood Gates: Vaptans, Furosemide and the Quest for a Renal Protective Diuresis

Journal of cardiac failure, 2011-12, Vol.17 (12), p.990-992

2011

Volltextzugriff (PDF)

Targeting Heme-Oxidized Soluble Guanylate Cyclase in Experimental Heart Failure

Hypertension (Dallas, Tex. 1979), 2007-05, Vol.49 (5), p.1128-1133

2007

Volltextzugriff (PDF)

1 – 25 von 115

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(111)
Mit Volltextzugriff
(109)

Publikationsform

Sprache

Englisch
(115)
Japanisch
(15)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Human Hypertension Is Characterized by a Lack of Activation of the Antihypertensive Cardiac Hormones ANP and BNP

Neutral endopeptidase inhibition and the natriuretic peptide system: an evolving strategy in cardiovascular therapeutics

Vasopressin-2-receptor antagonism augments water excretion without changes in renal hemodynamics or sodium and potassium excretion in human heart failure

Spatial Relationship of Focal Impulses, Rotors and Low Voltage Zones in Patients With Persistent Atrial Fibrillation

A Genetic Variant of the Atrial Natriuretic Peptide Gene Is Associated With Cardiometabolic Protection in the General Community

Natriuretic Peptides in the Diagnosis and Management of Chronic Heart Failure

Impaired Natriuretic and Renal Endocrine Response to Acute Volume Expansion in Pre-Clinical Systolic and Diastolic Dysfunction

Transcatheter Aortic Valve Implantation: Addressing the Subsequent Risk of Permanent Pacemaker Implantation

Brain Natriuretic Peptide Is Produced in Cardiac Fibroblasts and Induces Matrix Metalloproteinases

Pre-procedural predictors for multiple clips in percutaneous edge-to-edge mitral valve repair

Des-serine-proline brain natriuretic peptide 3-32 in cardiorenal regulation

Sustained Blood Pressure–Lowering Actions of Subcutaneous B-Type Natriuretic Peptide (Nesiritide) in a Patient With Uncontrolled Hypertension

The novel use of retrograde CTO PCI techniques as a rescue strategy for an acute right coronary artery occlusion due to iatrogenic dissection

Cardiac Resynchronization Therapy Improves Renal Function in Human Heart Failure With Reduced Glomerular Filtration Rate

Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure

Cardiorenal and humoral properties of a novel direct soluble guanylate cyclase stimulator BAY 41-2272 in experimental congestive heart failure

Matrix metalloproteinases: pathways of induction by bioactive molecules

Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community : Determinants and detection of left ventricular dysfunction

The Effect of the Brain-Type Natriuretic Peptide Single-Nucleotide Polymorphism rs198389 on Test Characteristics of Common Assays

Cardiac natriuretic peptides: contributors to cardiac cachexia or possible anti-obesity agents or both?

Renal and anti-aldosterone actions of vasopressin-2 receptor antagonism and B-type natriuretic peptide in experimental heart failure

Secretion of Prohormone of B-Type Natriuretic Peptide, proBNP1-108 , Is Increased in Heart Failure

Oral human brain natriuretic peptide activates cyclic guanosine 3',5'-monophosphate and decreases mean arterial pressure

Controlling the Flood Gates: Vaptans, Furosemide and the Quest for a Renal Protective Diuresis

Targeting Heme-Oxidized Soluble Guanylate Cyclase in Experimental Heart Failure

Suchergebnisse filtern